ResearcherHarbin Medical UniversityActive in the last 2 years
Hongze Chen
Matched on ORCID iD 0009-0000-2892-5441; OpenAlex author ID A5113016364. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- Correction: UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. Co-author DOI 10.1186/s13046-026-03696-5↗
- RBX1+ CAFs Drives Pancreatic Ductal Adenocarcinoma Progression Through Tenascin C Overexpression. Co-author DOI 10.3390/cancers18061024↗
- DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216288↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Le Li · 2 shared papers, 2023–2026 · strength 0.42
- Paper Correction: UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targ… DOI 10.1186/s13046-026-03696-5↗
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Bei Sun · 2 shared papers, 2023–2026 · strength 0.42
- Paper Correction: UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targ… DOI 10.1186/s13046-026-03696-5↗
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- X W Bai · 1 shared paper, 2026 · strength 0.30
- Chengxiao Yang · 1 shared paper, 2026 · strength 0.30
- Qinwen Zuo · 1 shared paper, 2026 · strength 0.30
- Chundong Cheng · 1 shared paper, 2026 · strength 0.27
- Shangha Pan · 1 shared paper, 2026 · strength 0.27
- Xinglong Geng · 1 shared paper, 2023 · strength 0.15
- Yan Luo · 1 shared paper, 2023 · strength 0.15
- Liwei Liu · 1 shared paper, 2023 · strength 0.15
- Wenbo Yang · 1 shared paper, 2023 · strength 0.15
- Rui Kong · 1 shared paper, 2023 · strength 0.15
- Zhongjie Zhao · 1 shared paper, 2023 · strength 0.15
- Yangyang Zhang · 1 shared paper, 2023 · strength 0.15
- Danxi Liu · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.